Aliases & Classifications for Atopy

Aliases & Descriptions for Atopy:

Name: Atopy 54 66 66 13 52 69
Hypersensitivity, Immediate 42
Ige Responsiveness, Atopic 29
Immediate Hypersensitivity 69
Atopic Hypersensitivity 66

Characteristics:

HPO:

32
atopy:
Inheritance autosomal dominant inheritance


Classifications:



External Ids:

OMIM 54 147050
MeSH 42 D006969

Summaries for Atopy

UniProtKB/Swiss-Prot : 66 Atopic hypersensitivity: A condition characterized by predisposition to develop hypersensitivity reactions. Atopic individuals can develop eczema, allergic rhinitis and allergic asthma.

MalaCards based summary : Atopy, also known as hypersensitivity, immediate, is related to pulmonary tuberculosis and asthma, and has symptoms including asthma, eczema and increased ige level. An important gene associated with Atopy is IL4R (Interleukin 4 Receptor), and among its related pathways/superpathways are Innate Immune System and PEDF Induced Signaling. The drugs Nitric Oxide and Dexamethasone have been mentioned in the context of this disorder. Affiliated tissues include testes, lung and t cells, and related phenotypes are hematopoietic system and homeostasis/metabolism

Wikipedia : 71 Atopy is a predisposition toward developing certain allergic hypersensitivity... more...

Description from OMIM: 147050

Related Diseases for Atopy

Diseases related to Atopy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 246)
id Related Disease Score Top Affiliating Genes
1 pulmonary tuberculosis 29.4 IFNG IGHE IL10 IL13 IL4 IL4R
2 asthma 11.3
3 peeling skin syndrome 1 10.9
4 asthma 2 10.8
5 asthma susceptibility 5 10.8
6 asthma 1 10.8
7 asthma-related traits 7 10.8
8 peeling skin syndrome 3 10.8
9 churg-strauss syndrome 10.7
10 eosinophilic granulomatosis with polyangiitis 10.7
11 platelet-activating factor acetylhydrolase deficiency 10.7
12 keratosis follicularis spinulosa decalvans 10.7
13 immunodeficiency 23 10.7
14 asthma-related traits 4 10.7
15 asthma-related traits 6 10.7
16 asthma-related traits 3 10.7
17 allergic angiitis 10.7
18 myoglobinuria recurrent 10.4 IFNG IL4
19 thelaziasis 10.4 IL13 IL4 IL5
20 marasmus 10.4 IL4 IL5 RNASE3
21 lymphoblastic leukemia 10.4 IL13 IL4 IL5
22 hyperinsulinism due to glutamodehydrogenase deficiency 10.4 IFNG IGHE IL4
23 lens-induced iridocyclitis 10.4 IL4 IL5 RNASE3
24 lactose intolerance 10.4 IL13 IL4 IL5
25 renal hypertension 10.4 IL13 IL5 RNASE3
26 askin's tumor 10.4 IL13 IL4 IL5
27 tubular renal disease-cardiomyopathy syndrome 10.4 IL10 IL4
28 urethral intrinsic sphincter deficiency 10.4 IFNG IL4 IL5
29 lymphocytic gastritis 10.4 IL13 IL4 IL5
30 asymptomatic neurosyphilis 10.4 IFNG IL10 IL4
31 spastic diplegia 10.4 IFNG IL13 IL5
32 cerebral primitive neuroectodermal tumor 10.4 IL4 IL5 RNASE3
33 cutaneous fibrous histiocytoma 10.4 IFNG IL4 IL5
34 tungiasis 10.4 IFNG IL10 IL4
35 dahlberg borer newcomer syndrome 10.4 IL13 IL5 IL9
36 centronuclear myopathy 5 10.4 IFNG IL10 IL4
37 hemiplegia 10.4 IL10 IL13 IL4R
38 osteodysplasty precocious of danks mayne and kozlowski 10.4 IFNG IL10 IL4
39 childhood malignant mesenchymoma 10.4 IL13 IL5 RNASE3
40 brown shrimp allergy 10.4 IL10 IL5 RNASE3
41 neurotic disorder 10.4 IFNG IL10 IL4
42 apricot allergy 10.4 IGHE IL4 IL5 RNASE3
43 gastroschisis abdominal wall defects, included 10.4 IFNG IL5
44 tularemia 10.3 IFNG IL10 IL4
45 ectodermal dysplasia bartalos type 10.3 IFNG IL10 IL4
46 isolated klippel-feil syndrome 10.3 IFNG IGHE IL4 IL5
47 metal allergy 10.3 IL13 IL4R IL5 RNASE3
48 hypersensitivity vasculitis 10.3 IL4 IL5 STAT6
49 spastic paraplegia 3a, autosomal dominant 10.3 IL13 IL4 IL5 RNASE3
50 trachea leiomyoma 10.3 IL13 IL4 IL5 RNASE3

Graphical network of the top 20 diseases related to Atopy:



Diseases related to Atopy

Symptoms & Phenotypes for Atopy

Symptoms by clinical synopsis from OMIM:

147050

Clinical features from OMIM:

147050

Human phenotypes related to Atopy:

32
id Description HPO Frequency HPO Source Accession
1 asthma 32 HP:0002099
2 eczema 32 HP:0000964
3 increased ige level 32 HP:0003212

MGI Mouse Phenotypes related to Atopy:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.21 ADRB2 CD14 IFNG IL10 IL12RB2 IL13
2 homeostasis/metabolism MP:0005376 10.13 ADRB2 CD14 IL4 IL4R IL5 IL9
3 immune system MP:0005387 10.13 IL10 IL12RB2 IL13 IL4 IL4R IL5
4 digestive/alimentary MP:0005381 10.01 IFNG IL10 IL12RB2 IL13 IL4 IL4R
5 integument MP:0010771 9.76 IFNG IL10 IL13 IL4 IL4R SELP
6 liver/biliary system MP:0005370 9.56 IFNG IL10 IL12RB2 IL4 IL4R IL5
7 respiratory system MP:0005388 9.28 IL13 IL4 IL4R IL5 SELP STAT6

Drugs & Therapeutics for Atopy

Drugs for Atopy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1010)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Nitric Oxide Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 10102-43-9 145068
2
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-02-2 5743
3
Simvastatin Approved Phase 4,Phase 3,Phase 2 79902-63-9 54454
4
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 104987-11-3 445643 439492
5
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-78-2 2244
6
Midazolam Approved, Illicit Phase 4,Phase 1 59467-70-8 4192
7
Montelukast Approved Phase 4,Phase 3,Phase 2,Phase 1 158966-92-8 5281040
8
Bambuterol Approved Phase 4 81732-65-2, 81732-46-9 54766
9
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 75614-87-8, 51-45-6 774
10
Propranolol Approved, Investigational Phase 4,Phase 2 525-66-6 4946
11
Ticlopidine Approved Phase 4,Phase 2 55142-85-3 5472
12
Hydrocortisone Approved, Vet_approved Phase 4,Phase 2,Phase 1 50-23-7 5754 657311
13
Terbutaline Approved Phase 4,Phase 3,Phase 2 23031-25-6 5403
14
Betamethasone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 378-44-9 9782
15
Dexmedetomidine Approved, Vet_approved Phase 4 76631-46-4, 113775-47-6 68602 5311068 56032
16
Procaterol Approved Phase 4,Phase 3,Phase 2,Phase 1 72332-33-3 688561
17
Ipratropium Approved Phase 4,Phase 3,Phase 2,Phase 1 22254-24-6, 60205-81-4 43232
18
Ephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1 299-42-3 9294
19
Capsaicin Approved Phase 4,Phase 1 404-86-4 1548943
20
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-24-8 5755
21
Azelastine Approved Phase 4,Phase 3,Phase 2,Phase 1 58581-89-8 2267
22
Budesonide Approved Phase 4,Phase 3,Phase 2,Phase 1 51333-22-3 63006 5281004
23
Lidocaine Approved, Vet_approved Phase 4,Phase 1 137-58-6 3676
24
Ketotifen Approved Phase 4,Phase 3,Phase 2,Phase 1 34580-14-8, 34580-13-7 3827
25
Azithromycin Approved Phase 4,Phase 3,Phase 2,Phase 1 83905-01-5 55185 53477736 447043
26
Remifentanil Approved Phase 4 132875-61-7 60815
27
Citalopram Approved Phase 4 59729-33-8 2771
28
Levocetirizine Approved Phase 4,Phase 3,Phase 2,Phase 1 130018-77-8
29
Cetirizine Approved Phase 4,Phase 3,Phase 2,Phase 1 83881-51-0 2678
30
Loratadine Approved Phase 4,Phase 3,Phase 2,Phase 1 79794-75-5 3957
31
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
32
Desloratadine Approved, Investigational Phase 4,Phase 3,Phase 2 100643-71-8 124087
33
Lansoprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 103577-45-3 3883
34
Omalizumab Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 242138-07-4
35
Benzocaine Approved Phase 4,Phase 3,Phase 2,Phase 1 1994-09-7, 94-09-7 2337
36
Etomidate Approved Phase 4 33125-97-2 36339 667484
37
Pseudoephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1 90-82-4 7028
38
Menthol Approved Phase 4,Phase 3,Phase 2,Phase 1 2216-51-5 16666
39
Ertapenem Approved, Investigational Phase 4 153832-46-3 150610
40
Ciclesonide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 126544-47-6, 141845-82-1 444033
41
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345
42
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 83-43-2 6741
43
Fluocinonide Approved, Investigational Phase 4 356-12-7 9642
44
Desonide Approved, Investigational Phase 4,Phase 3 638-94-8 5311066
45
Alcaftadine Approved Phase 4,Phase 3 147084-10-4 19371515
46
Magnesium Sulfate Approved, Vet_approved Phase 4,Phase 3,Phase 2 7487-88-9 24083
47
Naphazoline Approved Phase 4,Phase 3 835-31-4 4436
48
Arsenic trioxide Approved, Investigational Phase 4 1327-53-3 518740
49
Pheniramine Approved Phase 4 86-21-5 4761
50
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 53-03-2 5865

Interventional clinical trials:

(show top 50) (show all 4729)
id Name Status NCT ID Phase
1 Safety of Ertapenem in Beta-lactam Allergic Patients. Unknown status NCT01159379 Phase 4
2 Effect of Xolair on Airway Hyperresponsiveness Unknown status NCT00208234 Phase 4
3 Ocular Allergy Treatment Practical Impact Trial Unknown status NCT01808768 Phase 4
4 Comparison of Tolerability Between Two Allergy Drops Unknown status NCT01390961 Phase 4
5 The Effect of BEPREVE 1.5% on Tear Film Osmolarity and Tear Film Lipid Layer Unknown status NCT01346371 Phase 4
6 Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses Unknown status NCT01337557 Phase 4
7 The Efficacy and Safety of Desloratadine With Levocetirizine in Treatment of Chronic Idiopathic Urticaria Unknown status NCT00346606 Phase 4
8 Effects of Montelukast in Asthmatic Children With and Without Food Allergy Unknown status NCT01618929 Phase 4
9 Effect of Specific Immunotherapy to Dust Mites in Children With Asthma Unknown status NCT00496561 Phase 4
10 Evaluation of Efficacy of House Dust Mite Immunotherapy in Children With Bronchial Asthma Unknown status NCT00496574 Phase 4
11 Comparative Study of Sinol and Sinol-M in Patients With Congestion Due to Allergic Rhinitis Unknown status NCT00825656 Phase 4
12 Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis Unknown status NCT02014623 Phase 4
13 Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 Mcg BID Unknown status NCT00235053 Phase 4
14 Fluticasone/Salmeterol (FP/SM) Versus Double the Dose Fluticasone (FP) in Patients With Mild to Moderate Asthma Unknown status NCT00830505 Phase 4
15 Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais Unknown status NCT01115595 Phase 4
16 Effects of Su-Huang Antitussive Capsule on Cough Variant Asthma Unknown status NCT01584804 Phase 4
17 Effects of Leukotriene Modulator Montelukast on Cough Variant Asthma Unknown status NCT01404013 Phase 4
18 Efficacy and Safety of Activation Energy Serum (AES) Versus Placebo in Persistent Asthma. Unknown status NCT01939951 Phase 4
19 Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites Unknown status NCT01052610 Phase 4
20 Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic Rhinitis Unknown status NCT00488176 Phase 4
21 Assessment of Utility of Exhaled Nitric Oxide Measurement for Treatment Monitoring in Children With Asthma Unknown status NCT00500253 Phase 4
22 Dietetic Versus Topical Steroids for Pediatric Eosinophilic Esophagitis Unknown status NCT01846962 Phase 4
23 The Effect of Bronchodilator on Eosinophilic Bronchitis and Cough Variant Asthma Unknown status NCT02002754 Phase 4
24 A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma Unknown status NCT00461812 Phase 4
25 Cosalin® Monotherapy Versus Cosalin® and Xarlin® Combination Therapy Unknown status NCT01062139 Phase 4
26 Efficacy of KAM2904 Face Cream and KAM3008 Body Lotion Treatment in Children With Atopic Dermatitis (AD) Unknown status NCT01781663 Phase 4
27 VANOS Cream and Skin Barrier Function Unknown status NCT00819507 Phase 4
28 Extra-fine Formoterol/Beclomethasone in Asthmatic Crisis Unknown status NCT02345993 Phase 4
29 Effect of Dexmedetomidine on Levels of Plasma Inflammatory Factor in Asthma Patients Undergoing General Anesthesia Unknown status NCT02289391 Phase 4
30 Comparison of Daily Mometasone Furoate Nasal Spray Alone Versus a Combination With Montelukast for Treatment of Chronic Rhinosinusitis With Asthma After Functional Endoscopic Sinus Surgery Unknown status NCT02110654 Phase 4
31 Effect of Vitamin D Supplementation on the Control of Asthma in Children at a South African Academic Hospital Unknown status NCT02053402 Phase 4
32 Improving Asthma Control in the Real World: A Systematic Approach to Improving Dulera Adherence Unknown status NCT02045875 Phase 4
33 Efficacy of Bronchial Thermoplasty in Korean Unknown status NCT02031263 Phase 4
34 Optimization of Inhaled Corticosteroid Treatment in Adult Patients With Asthma Guided by Exhaled NO Measurement at Home Unknown status NCT01783132 Phase 4
35 Noninvasive Positive Airway Pressure in the Pediatric Emergency Department for the Treatment of Acute Asthma Exacerbations Unknown status NCT01497691 Phase 4
36 Assessing Decision Maker Tools for Asthma: the Asthma APGAR Unknown status NCT01446315 Phase 4
37 Efficacy and Safety Study of Procaterol Hydrochloride to Treat Patients With Cough Variant Asthma (CVA) Unknown status NCT01170429 Phase 4
38 Concentrations of Salmeterol in Blood and Urine Unknown status NCT00914901 Phase 4
39 Terbutaline Concentrations in Blood and Urine Unknown status NCT00914797 Phase 4
40 Concentrations of Formoterol in Blood and Urine Unknown status NCT00914654 Phase 4
41 Rapid Onset Action of Salbutamol Versus Formoterol Unknown status NCT00900874 Phase 4
42 Vitamin D for the Treatment of Severe Asthma Unknown status NCT00712205 Phase 4
43 A Pilot Study Involving an Asthma Management Program for Inner-city Early Head Start Children Unknown status NCT00624429 Phase 4
44 Inflammatory, Functional and Image Composite Measure to Define Asthma Control Unknown status NCT00597064 Phase 4
45 Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma Unknown status NCT00576069 Phase 4
46 Treatment of Acute Asthma in ER With Combination of Systemic Steroids and Inhaled Steroids Unknown status NCT00397267 Phase 4
47 A Pilot Efficacy Study of Inhaled Albuterol Delivered With Akita Breath Control Unknown status NCT00385359 Phase 4
48 A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy. Unknown status NCT00237068 Phase 4
49 Effect of Moisturizing Creams on Skin Barrier Function Unknown status NCT00771121 Phase 4
50 POLlinosis and Exhaled Breath Temperature Unknown status NCT01785394 Phase 4

Search NIH Clinical Center for Atopy

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: hypersensitivity, immediate

Genetic Tests for Atopy

Genetic tests related to Atopy:

id Genetic test Affiliating Genes
1 Ige Responsiveness, Atopic 29

Anatomical Context for Atopy

MalaCards organs/tissues related to Atopy:

39
Testes, Lung, T Cells, Skin, Breast, Endothelial, Thyroid

Publications for Atopy

Articles related to Atopy:

(show top 50) (show all 917)
id Title Authors Year
1
Association of atopy phenotypes with new development of asthma and bronchial hyperresponsiveness in school-aged children. ( 28364972 )
2017
2
Persistent asthma phenotype related with late-onset, high atopy, and low socioeconomic status in school-aged Korean children. ( 28231776 )
2017
3
Wheezing, asthma, and atopy in premature infants at 2 years of age. ( 28425254 )
2017
4
Childhood atopy and mental health: a prospective, longitudinal investigation. ( 27762174 )
2017
5
Extract of Polygala tenuifolia Alleviates Stress-Exacerbated Atopy-Like Skin Dermatitis through the Modulation of Protein Kinase A and p38 Mitogen-Activated Protein Kinase Signaling Pathway. ( 28106783 )
2017
6
Type 1 diabetes in children and adolescents is not associated with a reduced prevalence of atopy and allergic diseases. ( 28239959 )
2017
7
The influence of gender and atopy in the relationship between obesity and asthma in childhood. ( 28126313 )
2017
8
Prediction of atopy via total immunoglobulin E levels andskin prick tests in patients with psoriasis. ( 28425249 )
2017
9
Vitamin D and Atopy. ( 28454657 )
2017
10
ERBIN deficiency links STAT3 and TGF-I^ pathway defects with atopy in humans. ( 28126831 )
2017
11
Is there any difference regarding atopy between children with familial Mediterranean fever and healthy controls? ( 28465037 )
2017
12
Life-course of atopy and allergy-related disease events in tropical sub-Saharan Africa: A birth cohort study. ( 28339128 )
2017
13
Risk Factors for Keratoconus: Atopy and Eye Rubbing. ( 27755195 )
2017
14
Influence of Atopy in the Outcome of Avulsed and Replanted Teeth during 5 Years of Follow-up. ( 27939740 )
2017
15
IL33 and IL1RL1 variants are associated with asthma and atopy in a Brazilian population. ( 28266165 )
2017
16
Correction: ERBIN deficiency links STAT3 and TGF-I^ pathway defects with atopy in humans. ( 28289052 )
2017
17
Reference Values and Utility of Serum Total Immunoglobulin E for Predicting Atopy and Allergic Diseases in Korean Schoolchildren. ( 28378554 )
2017
18
Co-occurrence of migraine and atopy in children and adolescents: myth or a casual relationship? ( 28248699 )
2017
19
Atopy, asthma, and the elderly: A paradigm for personalized therapy. ( 28441985 )
2017
20
Environmental control measures for the management of atopy. ( 28153081 )
2017
21
Patterns of Immune Development in Urban Preschoolers with Recurrent Wheeze and/or Atopy. ( 28089873 )
2017
22
Free 25(OH)D concentrations are associated with atopy and lung function in children with asthma. ( 28533007 )
2017
23
Effect of genetic factors on the development of atopy and reactivity to specific allergens: A twin study. ( 27298265 )
2016
24
Analysis of the impact of allergy and atopy on new onset of uveitis. ( 27682154 )
2016
25
The Interaction Between Prenatal Exposure to Home Renovation and Reactive Oxygen Species Genes in Cord Blood IgE Response is Modified by Maternal Atopy. ( 26540500 )
2016
26
"Cumulative Stress": The Effects of Maternal and Neonatal Oxidative Stress and Oxidative Stress-Inducible Genes on Programming of Atopy. ( 27504149 )
2016
27
Prenatal and early-life predictors of atopy and allergic disease in Canadian children: results of the Family Atherosclerosis Monitoring In earLY life (FAMILY) Study. ( 27453525 )
2016
28
Elevated blood eosinophils in early infancy are predictive of atopic dermatitis in children with risk for atopy. ( 27294404 )
2016
29
Probiotics for Prevention of Atopy and Food Hypersensitivity in Early Childhood: A PRISMA-Compliant Systematic Review and Meta-Analysis of Randomized Controlled Trials. ( 26937896 )
2016
30
Relationship between all fevers or fever after vaccination, and atopy and atopic disorders at 18 and 36 months. ( 27489787 )
2016
31
Utility of the Atopy Patch Test in the Diagnosis of Allergic Rhinitis. ( 27429944 )
2016
32
Atopy, but Not Obesity is Associated with Asthma Severity Among Children with Persistent Asthma. ( 27144330 )
2016
33
Gene expression profiling of asthma phenotypes demonstrates molecular signatures of atopy and asthma control. ( 26792209 )
2016
34
Urban Dust Microbiome: Impact on Later Atopy and Wheezing. ( 27232328 )
2016
35
Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. ( 27618652 )
2016
36
Skin disease of penis and male genitalia is linked to atopy and circumcision: caseload in a male genital dermatology clinic. ( 27170096 )
2016
37
Atopy and Specific Cancer Sites: a Review of Epidemiological Studies. ( 27277132 )
2016
38
Aeroallergens, atopy and allergic rhinitis in the Middle East. ( 26808447 )
2016
39
Evaluation of the Interleukin-1 Receptor Antagonist and Immunoregulatory Interleukin-10 in the Middle Ear in Chronic Otitis Media With Effusion in Children With and Without Atopy. ( 27090281 )
2016
40
Clinical Toxicology and Its Relevance to Asthma and Atopy. ( 27842794 )
2016
41
Association between obstructive sleep apnea and atopy in adult Maltese patients. ( 27576014 )
2016
42
The Developmental History of IgE and IgG4 Antibodies in Relation to Atopy, Eosinophilic Esophagitis, and the Modified TH2 Response. ( 27221343 )
2016
43
Microbiome and its impact on gastrointestinal atopy. ( 27240281 )
2016
44
Atopy patch test with house dust mite in Chinese patients with atopic dermatitis. ( 27329364 )
2016
45
Inverse Association Between Atopy and Melanoma: A Case-control Study. ( 27276655 )
2016
46
Impact of allergy and atopy on the risk of pseudophakic cystoid macular edema. ( 27553052 )
2016
47
Common environmental chemicals do not explain atopy contrast in the Finnish and Russian Karelia. ( 27047657 )
2016
48
Novel genetic diseases associated with atopy. ( 27773049 )
2016
49
Pharmacokinetics, Pharmacodynamics, and Safety of MEDI4212, an Anti-IgE Monoclonal Antibody, in Subjects with Atopy: A Phase I Study. ( 26843086 )
2016
50
Is Gianotti-Crosti Syndrome Associated with Atopy? A Case-Control Study and a Postulation on the Intrinsic Host Factors in Gianotti-Crosti Syndrome. ( 27339179 )
2016

Variations for Atopy

Expression for Atopy

Search GEO for disease gene expression data for Atopy.

Pathways for Atopy

Pathways related to Atopy according to GeneCards Suite gene sharing:

(show all 42)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
14.02 CD14 IFNG IGHE IL10 IL12RB2 IL13
2
Show member pathways
13.65 CD14 IFNG IL10 IL12RB2 IL13 IL4
3
Show member pathways
13.53 IFNG IL10 IL12RB2 IL13 IL4 IL4R
4
Show member pathways
13.4 IL10 IL12RB2 IL13 IL4 IL4R IL5
5
Show member pathways
13.36 IFNG IGHE IL10 IL12RB2 IL13 IL4
6
Show member pathways
13.29 IL10 IL12RB2 IL13 IL4 IL4R IL5
7
Show member pathways
12.85 IFNG IL10 IL13 IL4 IL5 IL9
8
Show member pathways
12.64 IFNG IGHE IL10 IL12RB2 IL4 IL4R
9
Show member pathways
12.6 IFNG IL10 IL12RB2 IL13 IL4 IL4R
10
Show member pathways
12.57 IGHE IL13 IL4 IL5 MS4A2
11 12.53 HAVCR1 IFNG IL10 IL4 STAT6
12
Show member pathways
12.43 IFNG IL10 IL4 IL5 IL9
13
Show member pathways
12.36 IGHE IL4 IL4R STAT6
14
Show member pathways
12.3 IFNG IL13 IL4 IL5
15
Show member pathways
12.18 IFNG IL10 IL13 IL4 IL5 IL9
16 12.02 CD14 IFNG IL10 IL4 IL5
17 12.01 IGHE IL10 IL13 IL4 IL4R STAT6
18
Show member pathways
11.98 IFNG IL12RB2 IL4 STAT6
19 11.89 CD14 IL4 IL4R IL5
20
Show member pathways
11.87 IFNG IL4 IL4R
21
Show member pathways
11.85 IFNG IL10 IL12RB2 IL13 IL4 IL4R
22 11.84 CD14 IFNG IL10
23 11.8 IL12RB2 IL4R STAT6
24 11.8 IFNG IL13 IL4 IL5
25 11.77 IFNG IL10 IL12RB2 IL13 IL4 IL5
26
Show member pathways
11.73 IFNG IL4 IL5
27 11.73 CD14 IFNG IL10
28 11.69 IL10 IL4 IL5
29 11.69 IFNG IL10 IL12RB2 STAT6
30 11.64 IL13 IL4 IL5
31 11.6 IGHE IL10 IL4 IL4R IL5 SELP
32 11.52 IL10 IL13 IL4
33 11.51 IFNG IL10 SELP
34 11.34 IFNG IL4 IL4R IL5
35 11.34 IFNG IL13 IL4 IL5 IL9
36 11.28 IFNG IL10 IL13